Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Smallpox Vaccine (Imvanex)

UK Health Security Agency

This public procurement record has 3 releases in its history.

Award

08 Sep 2026 at 17:22

UK6 - Contract Award Notice
Award

08 Sep 2026 at 17:18

UK5 - Transparency Notice
Planning

28 May 2026 at 11:44

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

The UK Health Security Agency, acting for the Secretary of State for Health and Social Care, procured the supply of Imvanex smallpox vaccine for the UK countermeasures stockpile. This is a goods requirement for vaccines, with delivery across the United Kingdom. The product is a third-generation smallpox vaccine intended for national health protection and emergency preparedness. The requirement concerns the vaccine itself rather than clinical services, logistics or wider medical provision. Suppliers operating in the pharmaceutical, vaccine manufacturing or specialist medical countermeasures markets are the relevant businesses. The buyer is a central government health security organisation, so suppliers would need to support a national stockpile and meet the regulatory and supply requirements associated with public health resilience.

The procurement is complete and was awarded by direct award to Bavarian Nordic A/S as a single supplier for a third-generation smallpox vaccine, under section 41. The award date was 8 September 2026. The recorded award value is £1 gross, in GBP. The award contract period runs from 1 October 2026 to 30 September 2029, with a renewal option of one further period and a maximum extent date of 30 September 2030. A signature milestone was due by 28 September 2026, and the standstill period ended on 18 September 2026. The tender’s stated contract period was 12 October 2026 to 11 October 2029. The lot is complete. The award was based on single-supplier technical reasons, with compliant licensing required.

This award demonstrates continuing public-sector demand for a licensed third-generation smallpox vaccine to support the UK’s national countermeasures stockpile. A credible future supplier would need an appropriate licensed product, established vaccine manufacturing capability and sufficient production capacity to support government stockpiling. Relevant capability includes providing clear product information, available dose, pack sizes and formats, unit and volume pricing, minimum order quantities, standard lead times and supply availability. Suppliers would also need to explain storage and handling requirements, including temperature controls, and provide shelf-life information suitable for stockpile management. Experience supplying regulated vaccines or comparable national health protection programmes would strengthen credibility, alongside the ability to maintain dependable long-term supply and meet UK regulatory requirements.

How relevant is this notice?

Notice Information

Notice Title

Smallpox Vaccine (Imvanex)

Notice Description

The supply of Smallpox Vaccine (Imvanex)

Planning Information

Suppliers are invited to submit responses including the following: Product Information: - Product name and description - Available dose/pack sizes and formats Pricing Information: - Unit pricing - Volume-based pricing and price breaks - Any minimum order quantities Lead Times and Supply: - Standard lead times - Availability and production capacity Regulatory / Licensing: - Licensing status Storage and Handling: - Storage conditions (e.g. temperature requirements) - Shelf life If your organisation is interested in this requirement, please provide the above information to commercial.preparednessandcountermeasures@ukhsa.gov.uk by COP 11th June 2026.

Procurement Information

Section 41 Single Supplier for third-generation smallpox vaccine

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06a761
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/085113-2026
Current Stage
Award
All Stages
Planning, Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651600 - Vaccines

Notice Value(s)

Tender Value
£1
Lots Value
Not specified
Awards Value
£1
Contracts Value
Not specified

Notice Dates

Publication Date
8 Sep 20264 weeks ago
Submission Deadline
Not specified
Future Notice Date
27 Jul 2026Expired
Award Date
8 Sep 20264 weeks ago
Contract Period
1 Oct 2026 - 30 Sep 2029 3-4 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
UK Health Security Agency
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Postcode Area
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Supplier Information

Number of Suppliers
1
Supplier Name

Bavarian Nordic A/S

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...